In 120 Chinese adults with chronic liver disease-related thrombocytopenia before elective invasive procedures, rhTPO vs placebo sustained platelets ≥50×10⁹/L without emergency bleeding management in 85.0% vs 12.5%; transfusion avoided in 92.5% vs 25.0%.
RCTn = 120
Han et al. Recombinant Human Thrombopoietin Reduces the Need for Platelet Transfusion in Patients With Chronic Liver Disease and Thrombocytopenia